Compound Summary
Nialamide
Compound Information
Nialamide
Compound Name: | Nialamide |
Compound CID: | 4472 |
Synonyms: | Nialamide Nialamid 51-12-7 Niamidal Niamid More... |
Iupac Name: | N-benzyl-3-[2-(pyridine-4-carbonyl)hydrazinyl]propanamide |
InChI: | InChI=1S/C16H18N4O2/c21-15(18-12-13-4-2-1-3-5-13)8-11-19-20-16(22)14-6-9-17-10-7-14/h1-7,9-10,19H,8,11-12H2,(H,18,21)(H,20,22) |
InChIKey: | NOIIUHRQUVNIDD-UHFFFAOYSA-N |
Canonical Smiles: | C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2 |
Isomeric Smiles: | C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2 |
Molecular Weight: | 298.34 |
Molecular Formula: | C16H18N4O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Nialamide
Molecular Weight: | 298.34 |
Molecular Formula: | C16H18N4O2 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 7 |
Heavy Atom Count: | 22 |
Complexity: | 350 |
Synonyms
Nialamide
| Nialamide | Nialamide |
|---|---|
Nialamide |
Nialamid |
51-12-7 |
Niamidal |
Niamid |
Niaquitil |
Niazin |
Psicodisten |
Novazid |
Nuredal |
Nyazin |
Surgex |
Mygal |
BEIH |
Delmoneurina |
Isalizina |
Espril |
Delmoneurinaesprilisalizina |
N-(2-(Benzylcarbamyl)ethylamino)isonicotinamide |
2-(2-(Benzylcarbamyl)ethyl)hydrazide isonicotinic acid |
UNII-T2Q0RYM725 |
2-(2-(Benzylcarbamoyl)ethyl)hydrazide isonicotinic acid |
P 1133 |
N-benzyl-3-2-(pyridine-4-carbonyl)hydrazinylpropanamide |
NSC 124514 |
N-Benzyl-3-(2-isonicotinoylhydrazino)propanamide |
N-Benzyl-beta-(isonicotinoylhydrazine)propionamide |
1-(2-(Benzylcarbamoyl)ethyl)-2-isonicotinoylhydrazine |
Isonicotinic acid, 2-(2-(benzylcarbamoyl)ethyl)hydrazide |
N-Isonicotinoyl-N(beta-N-benzylcarboxamidoethyl)hydrazine |
Isonicotinic acid 2-((2-benzylcarbamoyl)ethyl)hydrazide |
MLS000069474 |
T2Q0RYM725 |
4-Pyridinecarboxylic acid, 2-3-oxo-3-(phenylmethyl)aminopropylhydrazide |
NSC124514 |
1-2-(Benzylcarbamoyl)ethyl-2-isonicotinoylhydrazine |
CAS-51-12-7 |
Isonicotinic acid, 2-2-(benzylcarbamoyl)ethylhydrazide |
NCGC00015726-06 |
SMR000059131 |
DSSTox_CID_3362 |
4-Pyridinecarboxylic acid 2-(3-oxo-3-((phenylmethyl)amino)propyl)hydrazide |
Nialamidum INN-Latin |
DSSTox_RID_76991 |
DSSTox_GSID_23362 |
Nialamida INN-Spanish |
N-Benzyl-.beta.-(isonicotinylhydrazino)propionamide |
N-Benzyl-.beta.-(isonicotinoylhydrazine)propionamide |
2-2-(Benzylcarbamoyl)ethylhydrazide isonicotinic acid |
Nialamidum |
N-Isonicotinoyl-N-(.beta.-N-benzylcarboxamidoethyl)hydrazine |
Nialamida |
Nyezin |
4-Pyridinecarboxylic acid 2-3-oxo-3-(phenylmethyl)aminopropylhydrazide |
CCRIS 3512 |
N-Isonicotinyl hydrazide |
SR-01000000028 |
EINECS 200-079-3 |
Lopac-N-1392 |
Nialamide INN:BAN:NF |
BRN 0492941 |
HSDB 7698 |
Nialamide (INN) |
Nialamide, 95% |
Niamid (TN) |
N(sup1)-beta-Benzylcarbamoylethyl-N(sup2)-isonicotinoylhydrazine |
N(sup 1)-beta-Benzylcarbamoylethyl-N(sup 2)-isonicotinoylhydrazine |
Opera_ID_1336 |
Prestwick0_001099 |
Prestwick1_001099 |
Prestwick2_001099 |
Prestwick3_001099 |
CBChromo1_000220 |
Nucleic Acid Electrophoresis |
Lopac0_000865 |
SCHEMBL49430 |
BSPBio_001178 |
5-22-02-00251 (Beilstein Handbook Reference) |
MLS001076132 |
MLS001424258 |
SPBio_003059 |
WLN: T6NJ DVMM2VM1R |
BPBio1_001296 |
CHEMBL1256841 |
DTXSID1023362 |
Isonicitinic acid 2-(2-benzylcarbamoyl)ethylhydrazide |
Isonicotinic acid, 2-2-(benzylcarbamoylethylhydrazide |
CHEBI:94510 |
BDBM163693 |
HMS1571K20 |
HMS2052O21 |
HMS2089M13 |
HMS2093L10 |
HMS2098K20 |
HMS2233A06 |
HMS3262N11 |
HMS3372J15 |
HMS3394O21 |
HMS3715K20 |
Pharmakon1600-01505986 |
HY-B1199 |
ZINC1713761 |
Tox21_110208 |
Tox21_500865 |
2586AH |
NSC759298 |
AKOS003390166 |
Tox21_110208_1 |
CCG-101150 |
CS-4827 |
DB04820 |
LP00865 |
MCULE-7326088210 |
NC00400 |
NSC-124514 |
NSC-759298 |
SDCCGSBI-0050840.P003 |
NCGC00015726-01 |
NCGC00015726-02 |
NCGC00015726-03 |
NCGC00015726-04 |
NCGC00015726-05 |
NCGC00015726-07 |
NCGC00015726-08 |
NCGC00015726-09 |
NCGC00015726-11 |
NCGC00015726-16 |
NCGC00022832-03 |
NCGC00022832-04 |
NCGC00261550-01 |
SBI-0050840.P002 |
DB-051905 |
AB00384282 |
EU-0100865 |
FT-0631220 |
ST45022574 |
SW197230-4 |
D07337 |
N 1392 |
AB00384282-14 |
AB00384282_15 |
AB00384282_16 |
N-benzyl-3-(2-isonicotinoylhydrazinyl)propanamide |
N-Benzyl-3-(2-isonicotinoylhydrazino)propanamide # |
Q2359711 |
SR-01000000028-2 |
SR-01000000028-5 |
SR-01000000028-7 |
SR-01000000028-8 |
BRD-K12102668-001-04-0 |
N-benzyl-3-(4-pyridylcarbonylamino)aminopropanamide |
N1-.beta.-Benzylcarbamoylethyl-N2-isonicotinoylhydrazine |
N-benzyl-3-2-(pyridine-4-carbonyl)hydrazinopropanamide |
3-oxo(pyridin-4-yl)methylhydrazo-N-(phenylmethyl)propanamide |
Hydrazine, N-isonicotinoyl-N-beta-(N-benzylcarboxamido)ethyl- |
n(sup1)-.beta.-Benzylcarbamoylethyl-n(sup2)isonicotinoylhydrazine |
N-(phenylmethyl)-3-2-(pyridin-4-ylcarbonyl)hydrazinopropanamide |
N-Benzyl-3-N-(1-pyridin-4-yl-methanoyl)-hydrazino-propionamide |
4-Pyridinecarboxylic acid, 2-(3-oxo-3-((phenylmethyl)amino)propyl)hydrazide (9CI) |
Experimental Data
Nialamide
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 7.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Nialamide
Statistics Data
Nialamide
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 7.000000000000000 | 1 | 1 |
Statistics Data Visualization
Nialamide
